Pharmacokinetics Profiles of HQP1351 Under Fasting and High-fat Meals in Patients With Chronic Myeloid Leukemia

NCT03882281 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Myeloid Leukemia, Chronic Phase

Interventions

DRUG: HQP1351

Sponsor

Ascentage Pharma Group Inc.

Collaborators

[object Object]